Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 95

Similar articles for PubMed (Select 23543632)

1.

Design, synthesis, in vitro cytotoxicity evaluation and structure-activity relationship of goniothalamin analogs.

Mohideen M, Zulkepli S, Nik-Salleh NS, Zulkefeli M, Weber JF, Rahman AF.

Arch Pharm Res. 2013 Jul;36(7):812-31. doi: 10.1007/s12272-013-0099-1. Epub 2013 Mar 31. Erratum in: Arch Pharm Res. 2013 Jul;36(7):918. Weber, Jean-Frédéric Faizal Abdullah [corrected to Weber, Jean-Frédéric Faizal].

PMID:
23543632
2.

Synthesis of methoxylated goniothalamin, aza-goniothalamin and γ-pyrones and their in vitro evaluation against human cancer cells.

Barcelos RC, Pastre JC, Caixeta V, Vendramini-Costa DB, de Carvalho JE, Pilli RA.

Bioorg Med Chem. 2012 Jun 1;20(11):3635-51. doi: 10.1016/j.bmc.2012.03.059. Epub 2012 Apr 1.

3.

Design, synthesis and in vitro evaluation against human cancer cells of 5-methyl-5-styryl-2,5-dihydrofuran-2-ones, a new series of goniothalamin analogues.

Bruder M, Vendramini-Costa DB, de Carvalho JE, Pilli RA.

Bioorg Med Chem. 2013 Sep 1;21(17):5107-17. doi: 10.1016/j.bmc.2013.06.044. Epub 2013 Jun 27.

PMID:
23876338
4.

6-Bicycloaryl substituted (S)- and (R)-5,6-dihydro-2H-pyran-2-ones: asymmetric synthesis, and anti-proliferative properties.

Kasaplar P, Yilmazer O, Cağir A.

Bioorg Med Chem. 2009 Jan 1;17(1):311-8. doi: 10.1016/j.bmc.2008.10.069. Epub 2008 Nov 5.

PMID:
19022676
5.

Design, synthesis and in vitro cytotoxicity evaluation of 5-(2-carboxyethenyl)isatin derivatives as anticancer agents.

Han K, Zhou Y, Liu F, Guo Q, Wang P, Yang Y, Song B, Liu W, Yao Q, Teng Y, Yu P.

Bioorg Med Chem Lett. 2014 Jan 15;24(2):591-4. doi: 10.1016/j.bmcl.2013.12.001. Epub 2013 Dec 8.

PMID:
24360564
6.

Trypanocidal activity of 5,6-dihydropyran-2-ones against free trypomastigotes forms of Trypanosoma cruzi.

de Fátima A, Marquissolo C, de Albuquerque S, Carraro-Abrahão AA, Pilli RA.

Eur J Med Chem. 2006 Oct;41(10):1210-3. Epub 2006 Jul 3.

PMID:
16815596
7.

4-hydroxy-5,6-dihydropyrones. 2. Potent non-peptide inhibitors of HIV protease.

Tait BD, Hagen S, Domagala J, Ellsworth EL, Gajda C, Hamilton HW, Prasad JV, Ferguson D, Graham N, Hupe D, Nouhan C, Tummino PJ, Humblet C, Lunney EA, Pavlovsky A, Rubin J, Gracheck SJ, Baldwin ET, Bhat TN, Erickson JW, Gulnik SV, Liu B.

J Med Chem. 1997 Nov 7;40(23):3781-92.

PMID:
9371244
8.

Synthesis and evaluation of the molluscicidal activity of the 5,6-dimethyl-dihydro-pyran-2,4-dione and 6-substituted analogous.

de Souza LC, dos Santos AF, Sant'Ana AE, de Oliveira Imbroisi D.

Bioorg Med Chem. 2004 Mar 1;12(5):865-9.

PMID:
14980598
10.

Structure-anti-leukemic activity relationship study of ortho-dihydroxycoumarins in U-937 cells: key role of the δ-lactone ring in determining differentiation-inducing potency and selective pro-apoptotic action.

Vázquez R, Riveiro ME, Vermeulen M, Alonso E, Mondillo C, Facorro G, Piehl L, Gómez N, Moglioni A, Fernández N, Baldi A, Shayo C, Davio C.

Bioorg Med Chem. 2012 Sep 15;20(18):5537-49. doi: 10.1016/j.bmc.2012.07.043. Epub 2012 Aug 2.

PMID:
22925447
11.

Synthesis and antimicrobial properties of 2H-pyran-3(6H)-one derivatives and related compounds.

Georgiadis MP, Couladouros EA, Delitheos AK.

J Pharm Sci. 1992 Nov;81(11):1126-31.

PMID:
1447718
12.
13.

Synthesis and cytotoxic activity of fluorinated analogues of Goniothalamus lactones. Impact of fluorine on oxidative processes.

Dumitrescu L, Mai Huong DT, Van Hung N, Crousse B, Bonnet-Delpon D.

Eur J Med Chem. 2010 Jul;45(7):3213-8. doi: 10.1016/j.ejmech.2010.03.032. Epub 2010 Mar 25.

PMID:
20392543
14.

4-hydroxy-5,6-dihydro-2H-pyran-2-ones.3. Bicyclic and hetero-aromatic ring systems as 3-position scaffolds to bind to S1' and S2' of the HIV-1 protease enzyme.

Ellsworth EL, Domagala J, Prasad JV, Hagen S, Ferguson D, Holler T, Hupe D, Graham N, Nouhan C, Tummino PJ, Zeikus G, Lunney EA.

Bioorg Med Chem Lett. 1999 Jul 19;9(14):2019-24.

PMID:
10450973
15.

Nonpeptidic potent HIV-1 protease inhibitors: (4-hydroxy-6-phenyl-2-oxo-2H- pyran-3-yl)thiomethanes that span P1-P2' subsites in a unique mode of active site binding.

Prasad JV, Para KS, Tummino PJ, Ferguson D, McQuade TJ, Lunney EA, Rapundalo ST, Batley BL, Hingorani G, Domagala JM, et al.

J Med Chem. 1995 Mar 17;38(6):898-905.

PMID:
7699705
16.

Stereoselective synthesis and biological evaluation of (R)-rugulactone, (6R)-((4R)-hydroxy-6-phenyl-hex-2-enyl)-5,6-dihydro-pyran-2-one and its 4S epimer.

Reddy DK, Shekhar V, Prabhakar P, Chinna Babu B, Siddhardha B, Murthy US, Venkateswarlu Y.

Eur J Med Chem. 2010 Oct;45(10):4657-63. doi: 10.1016/j.ejmech.2010.07.036. Epub 2010 Jul 24.

PMID:
20705370
17.

Selective cytotoxicity of goniothalamin against hepatoblastoma HepG2 cells.

Al-Qubaisi M, Rozita R, Yeap SK, Omar AR, Ali AM, Alitheen NB.

Molecules. 2011 Apr 6;16(4):2944-59. doi: 10.3390/molecules16042944.

18.

Structure-based design of HIV protease inhibitors: 5,6-dihydro-4-hydroxy-2-pyrones as effective, nonpeptidic inhibitors.

Thaisrivongs S, Romero DL, Tommasi RA, Janakiraman MN, Strohbach JW, Turner SR, Biles C, Morge RR, Johnson PD, Aristoff PA, Tomich PK, Lynn JC, Horng MM, Chong KT, Hinshaw RR, Howe WJ, Finzel BC, Watenpaugh KD.

J Med Chem. 1996 Nov 8;39(23):4630-42.

PMID:
8917652
19.

Syntheses and biological activities of dihydro-5,6-dehydrokawain derivatives.

Tawata S, Taira S, Kobamoto N, Ishihara M, Toyama S.

Biosci Biotechnol Biochem. 1996 Oct;60(10):1643-5.

20.

Inhibitors of cholesterol biosynthesis. 3. Tetrahydro-4-hydroxy-6-[2-(1H-pyrrol-1-yl)ethyl]-2H-pyran-2-one inhibitors of HMG-CoA reductase. 2. Effects of introducing substituents at positions three and four of the pyrrole nucleus.

Roth BD, Blankley CJ, Chucholowski AW, Ferguson E, Hoefle ML, Ortwine DF, Newton RS, Sekerke CS, Sliskovic DR, Stratton CD, et al.

J Med Chem. 1991 Jan;34(1):357-66.

PMID:
1992137
Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk